The Harbinger talked to a polysomnographic specialist with Saint Luke's Sleep Disorders Program about the negative effects of sleep deprivation in high schoolers.
Medscape talked to Dr. Mikhail Kosiborod about how clinicians can be more diligent in evaluating people at high risk for developing heart failure with reduced ejection fraction.
Dapagliflozin reduces risk for worsening heart failure and cardiovascular death in adults with heart failure with mildly reduced or preserved ejection fraction, regardless of baseline HbA1c.
Health IT Analytics talked to Jane Peck about Saint Luke's collaboration with care operations company Qventus to help increase efficiency with a growing demand for surgical services.
